|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2017
Blackwell, K.; Gascon, P.; Jones, C. M.; Nixon, A.; Krendyukov, A.; Nakov, R.; Li, Y. und Harbeck, N.
(2017):
Pooled analysis of two randomized, double-blind trials comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer.
In: Annals of Oncology, Bd. 28, Nr. 9: S. 2272-2277
2016
Harbeck, N.; Zbarskaya, I.; Lipatov, O.; Frolova, M.; Udovitsa, D.; Topuzov, E.; Ganea-Motan, D. E.; Nakov, R.; Singh, P.; Rudy, A. und Blackwell, K.
(2016):
A randomized, double-blind trial to compare the efficacy and safety of proposed biosimilar pegfilgrastim (LA-EP2006) with reference pegfilgrastim in patients with breast cancer (PROTECT1).
In: Cancer Research, Bd. 76
Harbeck, N.; Gascon, P.; Jones, C. M.; Nixon, A.; Krendyukov, A.; Nakov, R.; Mo, M. und Blackwell, K. L.
(2016):
Proposed biosimilar pegfilgrastim (LA-EP2006) compared with reference pegfilgrastim in Asian patients with breast cancer receiving myelotoxic chemotherapy: Pooled subgroup analysis of two randomized trials.
In: Annals of Oncology, Bd. 27